within Pharmacolibrary.Drugs.ATC.A;

model A08AA03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.81,
    Cl             = 0.008433333333333333,
    adminDuration  = 600,
    adminMass      = 0.075,
    adminCount     = 1,
    Vd             = 0.00279,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.004266666666666667,
    Tlag           = 10.200000000000001
  );

  annotation(Documentation(
    info ="<html><body><p>Amfepramone (also known as diethylpropion) is a sympathomimetic amine used as an appetite suppressant in the short-term treatment of obesity. It acts as a centrally acting stimulant with pharmacological effects similar to amphetamines but is considered to have a lower potential for abuse. Amfepramone is approved for weight management in several countries but is not approved or is withdrawn in others (including the USA and many EU countries) due to safety concerns.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers after single oral administration.</p><h4>References</h4><ol><li><p>Dangor, CM, et al., &amp; Veltman, AM (1987). Bioavailability of amfepramone hydrochloride sustained release pellets formulation in healthy subjects. <i>Arzneimittel-Forschung</i> 37(6) 736–739. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3663274/&quot;>https://pubmed.ncbi.nlm.nih.gov/3663274</a></p></li><li><p>Beckett, AH, &amp; Stanojcić, M (1987). Re-evaluation of the metabolism and excretion of diethylpropion in non-sustained and sustained release formulations. <i>The Journal of pharmacy and pharmacology</i> 39(6) 409–415. DOI:<a href=&quot;https://doi.org/10.1111/j.2042-7158.1987.tb03411.x&quot;>10.1111/j.2042-7158.1987.tb03411.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2886596/&quot;>https://pubmed.ncbi.nlm.nih.gov/2886596</a></p></li><li><p>Markantonis, SL, et al., &amp; Beckett, AH (1986). Evaluation of the percutaneous absorption and metabolism of some aminopropiophenones. <i>The Journal of pharmacy and pharmacology</i> 38(7) 515–519. DOI:<a href=&quot;https://doi.org/10.1111/j.2042-7158.1986.tb04626.x&quot;>10.1111/j.2042-7158.1986.tb04626.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2875152/&quot;>https://pubmed.ncbi.nlm.nih.gov/2875152</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end A08AA03;
